Pharmabiz

Pharmexcil targets Dutch market access with focused Indian pharma delegation to boost exports and drive business

Pharmexcil targets Dutch market access with focused Indian pharma delegation to boost exports and drive business: Shardul Nautiyal, Mumbai Thursday, October 8, 2026, 08:00 Hrs [IS ...
Pharmabiz

DCC rejects proposal to revisit Schedule K on matters related to dispensing of medicines by RMP

DCC rejects proposal to revisit Schedule K on matters related to dispensing of medicines by RMP: Gireesh Babu, New Delhi Thursday, October 8, 2026, 08:00 Hrs [IST] The Drugs Consu ...
Pharmabiz

Opportunity for clinical research leaders lies in translating regulatory expectations into practical execution: Durga Mane

Opportunity for clinical research leaders lies in translating regulatory expectations into practical execution: Durga Mane: Yash Ved, Mumbai Thursday, October 8, 2026, 08:00 Hrs [ ...
Pharmabiz

Indian botanicals sector working to unlock their potential with advanced research, rigorous sourcing & standardisation

Indian botanicals sector working to unlock their potential with advanced research, rigorous sourcing & standardisation: Nandita Vijayasimha, Bengaluru Thursday, October 8, 2026, 0 ...
Pharmabiz

Hyderabad Customs programme to decode export schemes, duty-free imports and compliance

Hyderabad Customs programme to decode export schemes, duty-free imports and compliance: Shardul Nautiyal, Mumbai Thursday, October 8, 2026, 08:00 Hrs [IST] Pharma exporters, manuf ...
Pharmabiz

TNCDA seeks Central intervention over drug price mark-ups and corporate pharmacy expansion

TNCDA seeks Central intervention over drug price mark-ups and corporate pharmacy expansion: Peethaambaran Kunnathoor, Chennai Thursday, October 8, 2026, 08:00 Hrs [IST] Following ...
Pharmabiz

CureMeAbroad raises $1.1 million in pre-seed round led by SteerX Ventures with existing investor AIRA

CureMeAbroad raises $1.1 million in pre-seed round led by SteerX Ventures with existing investor AIRA: Our Bureau, Bengaluru ...
Pharmabiz

Granules India files Paragraph IV certification on Ruxolitinib ER tablets

Granules India files Paragraph IV certification on Ruxolitinib ER tablets: Our Bureau, Mumbai Wednesday, October 7, 2026, 17:15 Hrs [IST] Granules India Limited announced that it ...
Pharmabiz

US FDA accepts and grants priority review status to BridgeBio’s NDA of oral infigratinib for children with achondroplasia

US FDA accepts and grants priority review status to BridgeBio’s NDA of oral infigratinib for children with achondroplasia: Palo Alto, California Wednesday, October 7, 2026, 17:0 ...
Pharmabiz

ZEISS India inks a multi-year strategic pacts with Dr Agarwal’s Eye Hospital and Narayana Nethralaya

ZEISS India inks a multi-year strategic pacts with Dr Agarwal’s Eye Hospital and Narayana Nethralaya: Our Bureau, Bengaluru Wednesday, October 7, 2026, 16:30 Hrs [IST] ZEISS Ind ...
Pharmabiz

ArriVent’s FURVENT phase 3 trial of firmonertinib in first-line EGFR Exon 20 insertion mutant NSCLC fails to meet primary endpoint

ArriVent’s FURVENT phase 3 trial of firmonertinib in first-line EGFR Exon 20 insertion mutant NSCLC fails to meet primary endpoint: Newtown Square, Pennsylvania Wednesday, Octob ...
Pharmabiz

Vitalant launches cell-based analytics lab to support allogeneic therapy developers

Vitalant launches cell-based analytics lab to support allogeneic therapy developers: Phoenix Wednesday, October 7, 2026, 18:00 Hrs [IST] Vitalant, one of the nation’s largest no ...